Elizabeth Kelly

Managing Director

Elizabeth re-joined Pappas Capital in 2021 and works across funds, including Pappas Ventures and Asia Innovation Ventures (AIV), the firm’s newest specialized fund. She led AIV’s investments in Horizon Quantum Computing, NuProbe, RoboCT, Us2.ai, and VFlowTech, and serves as a board observer for Horizon and VFlowTech.

Prior to Pappas, she invested in digital health and healthcare technology companies at Echo Health Ventures, and its predecessor, Mosaic Health Solutions, both subsidiaries of Blue Cross NC. Prior to Mosaic, Elizabeth had a variety of cross-functional responsibilities at Chimerix (NASDAQ: CMRX), a biopharmaceutical company developing antiviral therapies for immunocompromised transplant patients. In addition to playing a leadership role in the company’s 2013 IPO, she spearheaded activities in corporate development, finance, marketing, IR, and PR. She began her career as an Analyst at Pappas Ventures, where she managed the deal flow process, supported portfolio companies, and contributed to fundraising efforts for a new venture fund.


University of North Carolina at Chapel Hill – Kenan-Flagler Business School (MBA in Finance, Entrepreneurship)
University of North Carolina at Chapel Hill (BA in Management, Spanish)

Serves as an Observer for: